Ann Cunningham

Ann Cunningham

Direttore/Membro del Consiglio presso VISTAGEN THERAPEUTICS, INC.

Patrimonio netto: - $ in data 31/10/2026

58 anni
Health Technology
Consumer Services

Profilo

Ms. Ann Cunningham is an Independent Non-Executive Director at Alterity Therapeutics Ltd. and an Independent Director at Vistagen Therapeutics, Inc. She is on the Board of Directors at Alterity Therapeutics Ltd. and Vistagen Therapeutics, Inc. Ms. Cunningham was previously employed as a Vice President-Neurodegenerative Disease by Teva Pharmaceutical Industries Ltd., a Senior Marketing Director by Otsuka America Pharmaceutical, Inc., a Senior Director-Global Brand by Eli Lilly & Co., and a Managing Partner by I3 Strategy Partners LLC.
She received her undergraduate degree from Yale University and an MBA from Stephen M.
Ross School of Business.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
22/07/2026 0 ( -.--% ) - $ 31/10/2026

Posizioni attive di Ann Cunningham

SocietàPosizioneInizio
VISTAGEN THERAPEUTICS, INC. Direttore/Membro del Consiglio 10/01/2019
ALTERITY THERAPEUTICS LIMITED Direttore/Membro del Consiglio 17/04/2026

Precedenti posizioni note di Ann Cunningham

SocietàPosizioneFine
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 01/01/2018
Corporate Officer/Principal 01/01/2015
ELI LILLY AND COMPANY Corporate Officer/Principal 01/01/2013
I3 Strategy Partners LLC
Fondatore -
Vedi nel dettaglio l'esperienza di Ann Cunningham

Formazione di Ann Cunningham

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

83

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

I3 Strategy Partners LLC

  1. Mercati
  2. Insider
  3. Ann Cunningham